Quest Diagnostics will work on a blood test for cancer risk it says may help identify people who could benefit from more frequent screenings using technology developed at the MD Anderson Cancer Center ...

(RTTNews) - Quest Diagnostics Incorporated (DGX), a provider of diagnostic information services, Tuesday said it partnered with The University of Texas MD Anderson Cancer Center to develop a ...

In an oral presentation at the 2025 AAN Annual Meeting, Quest scientists presented data suggesting the test can accurately assess Alzheimer's disease pathology with greater than 90% sensitivity and ...

Quest Diagnostics Incorporated (NYSE:DGX) is one of the 7 most undervalued pot stocks to buy according to analysts. On June 10, the company said it is developing a Multi-Cancer Stratification (MCaST) ...

Credit: Getty Images. The AD-Detect™ Test for Alzheimer's Disease is a screening test that uses plasma from a single blood draw to evaluate the levels of amyloid beta proteins. A blood-based biomarker ...

For the first time, people worried about their risk of Alzheimer’s disease can go online, order a blood test and receive results in the privacy of their homes. This might seem appealing on the surface ...

In an oral presentation given this week at the American Academy of Neurology (AAN)'s Annual Meeting in San Diego, Quest researchers presented data demonstrating that the new test would have a positive ...

For the first time, people worried about their risk of Alzheimer’s disease can go online, order a blood test, and receive results in the privacy of their homes. This might seem appealing on the ...